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Background
HIV-1 evades the cell-mediated immune response by
escape mutations in CD8 epitopes during infection, and
possibly when exposed to a CD8 cell-stimulating vaccine.
Whereas immunodominant epitopes are frequently sub-
ject to escape mutation, infrequently targeted subdomi-
nant epitopes remain relatively conserved.
Methods
We have completed testing of an HIV vaccine based on 7
highly conserved, subdominant CD8 epitopes. The cohort
for this human study consists of 13 HIV-positive, HLA-
A02-positive Danish males. Immunological investiga-
tions have shown that the vaccine epitopes stimulate
epitope-specific CD8 responses in all vaccinees. CD8
responses were induced against several epitopes in most
patients.
To understand the molecular basis for these immune
responses, and to investigate possible escape mutations,
sequential sequences were obtained from cloned viral
RNA. We have investigated the sequence of targeted and
non-targeted CTL epitopes.
Results
We confirmed the presence of the vaccine epitope targets
in circulating virus of the vaccinees, to which immune
responses could be induced. Our results indicate limited
evolution in targeted epitopes despite the induction of
additional immunity towards these. However, in some
cases de novo immune responses are associated with viral
evolution in targeted epitopes.
Conclusion
We find evidence of escape mutations in HLA-A02
epitopes in HIV-1-positive patients after dendritic cell-
based therapeutic vaccination with CD8 epitopes.
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